Women Sociologists in the Midwest: A Status Update

In this article, an earlier study of the status of academic women sociologists in the Midwest that was extended to 1984-1985 is discussed. Type of appointment, rank, and chairpersons, as well as position in a Ph.D. rather than an M.A. program were used in the study as indicators of employment status. Midwest Sociological Society (MSS) leadership positions and participation in the annual MSS meeting served as indicators of professional participation. The results show that gains in employment status for women slowed in the 1980s. Employment of women in sociology department positions, especially in full-time positions and higher ranks, continued to lag behind the proportion of women Ph.D.s in the field. Women were overrepresented in the secondary labor market of part-time employment. However, women are now almost as likely to be employed in Ph.D. as well as M.A. programs. While gains in employment status generally slowed, professional participation has accelerated in recent years. Possible explanations for the differential penetrability of the two realms are offered. The appropriateness of statistical parity as a standard for evaluating equality in academic employment also is discussed. This article proposes that structural barriers to employment equity for women may not be more significant than direct discrimination

EQUAL ACCESS TO EQUAL WORK: A STUDY OF INTER-FIRM VARIATION IN THE OCCUPATIONAL INEQUALITY OF WOMEN.

EQUAL ACCESS TO EQUAL WORK: A STUDY OF INTER-FIRM VARIATION IN THE OCCUPATIONAL INEQUALITY OF WOMEN

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

The European Organisation for Research and Treatment of Cancer 58951 trial for children with acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL) addressed 3 randomized questions, including the evaluation of dexamethasone (DEX) versus prednisolone (PRED) in induction and, for average-risk patients, the evaluation of vincristine and corticosteroid pulses during continuation therapy. The corticosteroid used in the pulses was that assigned at induction. Overall, 411 patients were randomly assigned: 202 initially randomly assigned to PRED (60 mg/m2/d), 201 to DEX (6 mg/m2/d), and 8 nonrandomly assigned to PRED. At a median follow-up of 6.3 years, there were 19 versus 34 events for pulses versus no pulses; 6-year disease-free survival (DFS) rate was 90.6% (standard error [SE], 2.1%) and 82.8% (SE, 2.8%), respectively (hazard ratio [HR] = 0.54; 95% confidence interval, 0.31-0.94; P = .027). The effect of pulses was similar in the PRED (HR = 0.56) and DEX groups (HR = 0.59) but more pronounced in girls (HR = 0.24) than in boys (HR = 0.71). Grade 3 to 4 hepatic toxicity was 30% versus 40% in pulses versus no pulses group and grade 2 to 3 osteonecrosis was 4.4% versus 2%. For average-risk patients treated according to Berlin-Frankfurt-Muenster–based protocols, pulses should become a standard component of therapy. This trial was registered at www.clinicaltrials.gov as #NCT00003728